Bristol Myers Squibb
Prescription Drugs · Oncology Therapeutics

Bristol Myers Squibb: Ownership & structure

Bristol Myers Squibb operates through 7 legal entities in 5 countries.

Data updated Nov 21, 2026 · Back to the company report

Owners & entities

Bristol Myers Squibb operates through 7 legal entities in 5 countries.

Legal entities7 in 5 countries
Bristol-Myers Squibb Company
operator · US EIN 220790350
US
BRISTOL-MYERS SQUIBB FOUNDATION INC
related · US EIN 133127947
US
Oy Bristol-Myers Squibb Finland Ab
related
FI
ORG-0019
related
IT
3 more records: legal entities with their register numbers and links to each registerProUnlockor this company alone for 30 days · 50 credits
Subsidiaries in its annual report: 231 in 52 jurisdictions · United States 97, United Kingdom 15, Switzerland 14, Netherlands 13, Ireland 12 · sec.gov ↗
Stakes and purchases
Large holders (13D / 13G)holders of 5% or more, their newest filing
STATE STREET CORP
passive holder · SCHEDULE 13G · Aug 2026
VANGUARD CAPITAL MANAGEMENT LLC
passive holder · SCHEDULE 13G · Apr 2026
VANGUARD GROUP INC
passive holder · SCHEDULE 13G/A · Mar 2026
JPMORGAN CHASE & CO
passive holder · SCHEDULE 13G/A · Oct 2025
BlackRock, Inc.
passive holder · SCHEDULE 13G/A · Apr 2025
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months

Insiders bought $0 (0 people) and sold $2.3M (3 people) in the last 12 months.

Sold · EVP,Chief Med Offr,Head of Dev
6,249 shares at $64.57 · Sep 2026
$403k
Sold · SVP and Controller
500 shares at $67.50 · Aug 2026
$34k
Sold · EVP, Chief Financial Officer
25,519 shares at $61.60 · Apr 2026
$1.6M
Sold · EVP, Chief Financial Officer
4,481 shares at $62.05 · Apr 2026
$278k
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors5
24 portfolio companies: Huma, FEVO, Fabletics and 21 more
venBio PartnersVia a fund
43 portfolio companies: Sanofi, Insamo, Axent Biosciences and 40 more
Nextech InvestVia a fund
63 portfolio companies: Zymeworks, Vividion Therapeutics (Acquired), Zenith Therapeutics and 60 more
Kleiner PerkinsVia a fund
335 portfolio companies: Modal, Flapping Airplanes, Cognition and 332 more
NEAVia a fund
672 portfolio companies
Show all 5